Vaccination

US regulators give full approval to Pfizer COVID-19 vaccine

The U.S. gave full approval to Pfizer's COVID-19 vaccine Monday, potentially boosting public confidence in the shots and instantly opening the way for more universities, companies and local governments to make vaccinations ...

Diseases, Conditions, Syndromes

Major COVID-19 vaccine trial resumes in UK after safety review

Pharma giant AstraZeneca and Oxford University on Saturday said they had resumed a COVID-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.

Diseases, Conditions, Syndromes

Unusual late influenza spring-wave in Canada 2022

In a Eurosurveillance paper, researchers look into the impact of COVID-19 measures on influenza circulation in Canada between 2020 and 2022 and the vaccine effectiveness against late-season influenza illness due to A(H3N2) ...

page 1 from 6